Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is one of the most heterogeneous diseases in solid tumors and has limited therapeutic options. Due to the lack of appropriate targetable markers, the mainstay therapeutic strategy for patients with TNBC has been chemotherapy for the last several decades. Indeed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Won-Ji, Sohn, Joo Hyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540846/
https://www.ncbi.nlm.nih.gov/pubmed/34681231
http://dx.doi.org/10.3390/ph14101008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540846/
https://www.ncbi.nlm.nih.gov/pubmed/34681231
http://dx.doi.org/10.3390/ph14101008

Ejemplares similares